Literature DB >> 7072692

Treatment of recurrent antibiotic-associated pseudomembranous colitis.

F J Tedesco.   

Abstract

Eleven patients with relapses of antibiotic-associated pseudomembranous colitis were treated with a tapering dose schedule of vancomycin and cholestipol. All patients responded and have continued to be asymptomatic for follow-up periods of at least 6 wk. This tapering dose of vancomycin in conjunction with cholestipol appears to be warranted in patients with relapses of antibiotic-associated pseudomembranous colitis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7072692

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  14 in total

Review 1.  Review of medical and surgical management of Clostridium difficile infection.

Authors:  B Faris; A Blackmore; N Haboubi
Journal:  Tech Coloproctol       Date:  2010-05-08       Impact factor: 3.781

Review 2.  Drug-induced Clostridium difficile-associated disease.

Authors:  M L Job; N F Jacobs
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

Review 3.  Recurrent Clostridium difficile infection: From colonization to cure.

Authors:  Kelsey Shields; Roger V Araujo-Castillo; Thimmaiah G Theethira; Carolyn D Alonso; Ciaran P Kelly
Journal:  Anaerobe       Date:  2015-04-27       Impact factor: 3.331

4.  The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis.

Authors:  R E Ariano; G G Zhanel; G K Harding
Journal:  CMAJ       Date:  1990-05-15       Impact factor: 8.262

5.  Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection.

Authors:  J A Kink; J A Williams
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 6.  Clostridium difficile infection: clinical spectrum and approach to management.

Authors:  Chetana Vaishnavi
Journal:  Indian J Gastroenterol       Date:  2011-12-20

7.  Treatment of Recurrent Clostridium difficile Diarrhea.

Authors:  Elizabeth S Huebner; Christina M Surawicz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-03

8.  Toxin binding of tolevamer, a polyanionic drug that protects against antibiotic-associated diarrhea.

Authors:  William Braunlin; Qiuwei Xu; Patrick Hook; Richard Fitzpatrick; Jeffrey D Klinger; Robert Burrier; Caroline B Kurtz
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

9.  New antimicrobial agents for patients with Clostridium difficile infections.

Authors:  John G Bartlett
Journal:  Curr Infect Dis Rep       Date:  2009-01       Impact factor: 3.725

Review 10.  Clostridium difficile-associated diarrhea in adults.

Authors:  Susan M Poutanen; Andrew E Simor
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.